Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma

This study is testing a new PET/CT imaging agent called 18F-NY104 to see how well it can detect and visualize renal cell carcinoma (kidney cancer), including recurrent or metastatic disease. It is an imaging study, not a treatment trial. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with or are suspected to have kidney cancer (renal cell carcinoma), or there is suspicion of recurrence or spread after prior treatment - You have at least one measurable lesion on imaging - Your blood counts, liver, and kidney function are within acceptable ranges - You are willing to use effective contraception during and for 6 months after the study **You may NOT be eligible if...** - You have had major surgery or trauma within the past 4 weeks - You have a severe systemic infection or significant organ dysfunction - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.